NDC 0178-0500
Lithostat
Acetohydroxamic Acid
Lithostat is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Mission Pharmacal Company. The primary component is Acetohydroxamic Acid.
| Product ID | 0178-0500_78d320aa-12e6-5fe2-e053-2991aa0aceab |
| NDC | 0178-0500 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Lithostat |
| Generic Name | Acetohydroxamic Acid |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 1983-05-31 |
| Marketing Category | NDA / NDA |
| Application Number | NDA018749 |
| Labeler Name | Mission Pharmacal Company |
| Substance Name | ACETOHYDROXAMIC ACID |
| Active Ingredient Strength | 250 mg/1 |
| Pharm Classes | Urease Inhibitor [EPC],Urease Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
Packaging
NDC 0178-0500-01
100 TABLET in 1 BOTTLE (0178-0500-01)
| Marketing Start Date | 1983-05-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 0178-0500-01 [00178050001]
Lithostat TABLET
| Marketing Category | NDA |
| Application Number | NDA018749 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1983-05-31 |
| Inactivation Date | 2020-01-31 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| ACETOHYDROXAMIC ACID | 250 mg/1 |
OpenFDA Data
| SPL SET ID: | 6660b616-a82d-9109-19ce-2bdf9747acea |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
Pharmacological Class
- Urease Inhibitor [EPC]
- Urease Inhibitors [MoA]
Trademark Results [Lithostat]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 LITHOSTAT 77719923 3815514 Live/Registered |
Mission Pharmacal Company 2009-04-22 |
 LITHOSTAT 73451034 1308590 Dead/Cancelled |
Mission Pharmacal Company, Inc. 1983-11-03 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.